Sign in

You're signed outSign in or to get full access.

TB

TUPPERWARE BRANDS CORP (TUP)·Q3 2022 Earnings Summary

Executive Summary

  • Q3 revenue fell 20% YoY (14% CC) to $0.303B; GAAP diluted EPS from continuing ops was $(0.09) vs $1.14 LY; non-GAAP diluted EPS was $0.14 vs $1.19 LY, as volumes declined and inflation/FX headwinds persisted .
  • Sequential revenue declined versus Q2 ($0.340B → $0.303B) and non-GAAP EPS fell ($0.41 → $0.14); Adjusted EBITDA (per debt covenant) decreased to $29.9M from $38.1M in Q2 .
  • Liquidity tightened: cash fell to $103M; total debt was $704M; consolidated net leverage rose to 4.17x; management disclosed “substantial doubt” about ability to continue as a going concern without covenant relief/refinancing .
  • Management flagged Q4 tailwind from a 53rd week (+~5% sales; +~1% to full-year sales), new retail distribution in North America, and plans for further restructuring and inventory reduction in Q4 .

What Went Well and What Went Wrong

  • What Went Well

    • South America delivered positive sales growth (+1% YoY, +7% CC) with segment profit up 6% and margin of 20.3% on pricing and promotional campaigns .
    • Gross margin held at 64.9% (vs 65.8% LY) despite volume and cost pressures, aided by pricing actions; non-GAAP gross margin was 65.4% .
    • Retail expansion in North America: “some of our products [available] at a major US retailer early in the fourth quarter,” supporting the omnichannel strategy and potential brand reach .
  • What Went Wrong

    • Broad-based top-line pressure: net sales down 20% (14% CC), driven by lower sales force activity, China lockdowns, weaker European sentiment, and price elasticity impacts on volumes .
    • Europe weakness significant (net sales down 33%; segment profit down 86%; margin 3.3%), with ongoing geopolitical/macro pressures; Asia also materially down (sales −24%; profit −57%) .
    • Balance sheet strain and covenant risk: cash down to $103M (from $267M YE21), net leverage at 4.17x vs 4.5x covenant in Q3, with step-down to 4.25x in Q4/Q1 and “substantial doubt” about going concern absent amendments/refinancing .

Financial Results

MetricQ1 2022Q2 2022Q3 2022
Revenue ($USD Billions)$0.348 $0.340 $0.303
GAAP Diluted EPS (Continuing Ops)$0.05 $0.09 $(0.09)
Adjusted Diluted EPS (Non-GAAP, Continuing Ops)$0.12 $0.41 $0.14
Gross Margin % (GAAP)63.8% 64.9% 64.9%
Operating Income ($USD Millions, GAAP)$17.5 $24.8 $15.8
Operating Margin % (GAAP)5.0% 7.3% 5.2%
Operating Margin % (Non-GAAP)5.9% 11.1% 8.7%
Adjusted EBITDA ($USD Millions, per debt covenant)$32.8 $38.1 $29.9

Segment breakdown (Q3 2022)

SegmentNet Sales ($M)YoY %Segment Profit ($M)YoY %Segment Profit Margin
Asia85.4 (24)% 11.1 (57)% 13.0%
Europe60.8 (33)% 2.0 (86)% 3.3%
North America86.3 (16)% 5.7 (47)% 6.6%
South America70.3 1% 14.3 6% 20.3%
Total302.8 (20)%

KPIs and balance sheet (trend)

KPI / Balance SheetQ1 2022Q2 2022Q3 2022
Active Sales Force (Total)326,281 332,143 305,605
Consolidated Net Leverage Ratio2.88 3.13 4.17
Cash & Cash Equivalents ($M)$245.6 $118.8 $102.9
Total Debt ($M)$811.3 $702.2 $704.0

Notes on non-GAAP: Adjusted EPS excludes re-engineering, asset gains/losses, exit/other costs, consulting, hyperinflation effects, among others; see reconciliations for details .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Company outlook (EPS/OCF)FY 2022Withdrawn (May 4, 2022) No reinstatement provided in Q2/Q3 Maintained withdrawn
Sales (calendar effect)Q4 2022N/A53rd week adds ~5% to Q4 sales New disclosure
Sales (calendar effect)FY 2022N/A53rd week adds ~1% to full-year sales New disclosure
Covenant leverage limitQ3 2022Max 4.5x (amended Aug 1) 4.5x applied in Q3; stepping down to 4.25x in Q4’22 and Q1’23 Tightening (step-down confirmed)

The company also indicated additional Q4 restructuring actions and “stringent inventory reduction programs” given YTD revenue trends . No quantitative revenue/EPS/margin guidance was issued in Q3 .

Earnings Call Themes & Trends

TopicPrevious Mentions (Q1 & Q2 2022)Current Period (Q3 2022)Trend
Sales force activityLower recruiting/activity pressured sales across regions Continued lower activity; price elasticity also weighed on unit volumes Worsened
China lockdownsStrict COVID lockdowns hurt Asia and overall sales Ongoing lockdowns continued to impact Asia Pacific Persistent headwind
Europe macro/geopoliticsRussia/Ukraine conflict and sentiment shifts hurt demand Continuing declines amid “difficult macro” and geopolitical tensions Persistent headwind
Inflation/resin/logisticsSignificant inflation and resin/logistics costs pressured margins Higher resin/logistics and mix pressured margins; pricing actions partially offset Mixed; mitigation ongoing
Pricing actionsMitigating margin erosion; more favorable impact expected in 2H Broad-based price increases helped offset volume declines Ongoing lever
Omnichannel/retail expansionPlan to penetrate retail channels later in 2022 Launch of select products at a major US retailer in early Q4 Executed milestone
Balance sheet/covenantsCredit facility amended; leverage covenant temporarily higher Leverage at 4.17x; covenant steps down; “substantial doubt” about going concern without amendments/refinancing Deteriorated

Management Commentary

  • CEO tone on execution and headwinds: “We faced internal and external challenges… decelerating top line in Asia Pacific and North America, and continuing declines in Europe… partially offset by continued positive sales growth in South America… currency headwinds were more than expected” .
  • Strategy update: “Turnaround Plan continues; fixing the core, right sizing… divesting non-core assets and opening new channels… products available at a major US retailer early in the fourth quarter” .
  • CFO on discipline and actions: “We remain disciplined to ensure we are focused on meeting our debt covenants… we expect to take additional restructuring actions in the fourth quarter, as well as implementing stringent inventory reduction programs” .
  • Margin drivers: “Decrease [in gross margin] was driven by lower volumes, higher resin and logistics costs, and country and product mix, partially offset by additional pricing actions” .

Q&A Highlights

The Q3 2022 earnings call transcript could not be retrieved due to a document retrieval issue, so Q&A themes and detailed management responses are unavailable from the transcript for this recap. Management’s press release commentary emphasized retail expansion, pricing actions, restructuring, and covenant focus .

Estimates Context

  • Wall Street consensus (S&P Global) for Q1–Q3 2022 EPS and revenue was unavailable via our estimates feed for TUP at the time of this analysis; therefore, we cannot quantify beats/misses versus consensus for Q3 2022. Values retrieved from S&P Global.
  • Company provided no quantitative revenue/EPS guidance in Q3; narrative implies estimates may need to adjust lower near term given demand softness in Europe/Asia, sales force activity declines, and tighter balance sheet constraints, partially offset by pricing and retail channel contributions .

Key Takeaways for Investors

  • Demand/mix headwinds and sales force activity erosion continue to pressure topline; sequential step-down in Q3 non-GAAP profitability underscores execution and macro risks near term .
  • Liquidity and covenant risk are central: leverage at 4.17x with step-down to 4.25x in Q4/Q1 and explicit going-concern language—lender negotiations and capital structure actions are critical stock catalysts .
  • Pricing actions and South America strength are partial offsets; gross margin resilience (~65%) shows the brand’s pricing power, but volume elasticity remains a headwind .
  • Retail launch in early Q4 is a tangible omnichannel milestone that could broaden reach and reduce reliance on direct selling; monitor sell-through and potential margin implications .
  • Expect further restructuring and inventory reduction in Q4; near-term cash generation and working capital improvements will be closely watched given declining cash balances .
  • The 53rd week provides a modest mechanical boost to Q4 sales (+5%) and FY sales (+1%), but underlying demand trends and FX will determine quality of the print .
  • Without formal guidance and with estimates unavailable here, positioning should be driven by balance sheet outcomes, retail ramp evidence, and stabilization in Europe/Asia trends, which will likely dictate estimate revisions and stock direction .